Viewing Study NCT02663193


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-02-21 @ 5:47 PM
Study NCT ID: NCT02663193
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2016-01-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Sponsor: Janssen Scientific Affairs, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate Cancer View
None Observational study View
None Enzalutamide View
None Abiraterone Acetate View
None Prednisone View
None Tolerability View